GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 80 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,986 | -13.2% | 25,573 | -1.5% | 0.00% | – |
| Q2 2023 | $50,647 | -29.9% | 25,973 | 0.0% | 0.00% | – |
| Q1 2023 | $72,205 | -17.3% | 25,973 | +2.7% | 0.00% | – |
| Q4 2022 | $87,285 | +47.9% | 25,300 | +11.0% | 0.00% | – |
| Q3 2022 | $59,000 | +18.0% | 22,800 | +10.1% | 0.00% | – |
| Q2 2022 | $50,000 | -26.5% | 20,700 | +26.2% | 0.00% | – |
| Q1 2022 | $68,000 | -64.0% | 16,400 | +11.6% | 0.00% | – |
| Q4 2021 | $189,000 | -50.1% | 14,700 | -58.1% | 0.00% | -100.0% |
| Q3 2021 | $379,000 | +77.1% | 35,050 | +49.8% | 0.00% | – |
| Q2 2021 | $214,000 | -4.5% | 23,400 | -1.7% | 0.00% | -100.0% |
| Q1 2021 | $224,000 | +194.7% | 23,800 | +24.0% | 0.00% | – |
| Q4 2020 | $76,000 | +123.5% | 19,200 | +51.8% | 0.00% | – |
| Q3 2020 | $34,000 | – | 12,647 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $41,970,000 | 8.18% |
| Copernicus Capital Management, LLC | 37,000 | $349,000 | 5.64% |
| EcoR1 Capital, LLC | 3,421,287 | $32,263,000 | 1.43% |
| Palo Alto Investors LP | 2,298,382 | $21,674,000 | 1.24% |
| AlpInvest Partners B.V. | 226,866 | $2,139,000 | 1.06% |
| Stenahm Asset Managment Ltd | 150,000 | $1,415,000 | 1.00% |
| FRAZIER MANAGEMENT LLC | 1,030,878 | $9,721,000 | 0.78% |
| BVF INC/IL | 1,861,239 | $17,551,000 | 0.66% |
| Avidity Partners Management LP | 2,122,064 | $20,011,000 | 0.55% |
| Redmile Group, LLC | 2,448,158 | $23,086,000 | 0.32% |